Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.04445-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, Against Hepatitis C Virus Using a Novel in Vitro Pharmacodynamic System

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Redox Signaling in anIn VivoMurine Model of Low Magnitude Oscillatory Wall Shear Stress

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2011English

Differential Sensitivity Between Fks1p and Fks2p Against a Novel Β-1,3-Glucan Synthase Inhibitor, Aerothricin1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

SCY-078 Is Fungicidal Against Candida Species in Time-Kill Studies

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

APX001 Pharmacokinetic/Pharmacodynamic Target Determination Against Aspergillus Fumigatus in an in Vivo Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Pharmacodynamic Assessment of Ertapenem (MK-0826) Against Streptococcuspneumoniae in a Murine Neutropenic Thigh Infection Model

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2002English

Fatty Acid Synthase: A Novel Target for Antiglioma Therapy

British Journal of Cancer
Cancer ResearchOncology
2006English

MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy